IRCT20110811007297N8招募中2 期
Efficacy and Safety of Ophthalmic Probiotic Lysate on Ocular Surface Microbiota, Immunological and Clinical Outcomes of Patients With Dry Eye Syndrome
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Male or Female
- •18Best corrected vision>=9/10
- •Signed informed consent
- •Voluntary adherence to treatment
排除标准
- •Pregnancy/breastfeeding
- •Conjunctivitis
- •Thyroid disease
- •Rheumatologic diseases including Sjogren's syndrome
- •Neurologic conditions, including stroke, Bell's palsy, Parkinson's, trigeminal nerve problem
- •Refractive surgery (LASIK or PRK)
- •Other Eye Surgeries
- •HSV Keratitis
- •Medication/supplement use, including psychiatric medicines, OTC cold medicines, anti-histamines, beta-blockers, pain relievers, sleeping pills, diuretics, Hormones replacement, and oral contraceptives
- •Chemical splashes / injuries to the eyes
- •Contact lens use
- •Environmental (dusty, windy, hot/dry)
- •Any treatment for dry eye in previous 4 weeks (including lubricants, steroids, cyclosporine)
研究者
相似试验
已完成
2 期
Probiotic in Dry Eye SyndromesDry Eye SyndromeNCT04938908Shiraz University of Medical Sciences40
进行中（未招募）
不适用
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment ofGeographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) - Geographic Atrophy Treatment Evaluation (GATE)Geographic atrophy secondary to AMDMedDRA version: 9.1Level: LLTClassification code 10063947Term: Geographic atrophyEUCTR2008-007705-37-ATAlcon Research, Ltd750
进行中（未招募）
不适用
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment ofGeographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) - Geographic Atrophy Treatment Evaluation (GATE)Geographic atrophy secondary to AMDMedDRA version: 14.0Level: LLTClassification code 10063947Term: Geographic atrophySystem Organ Class: 10015919 - Eye disordersEUCTR2008-007705-37-PTAlcon Research, Ltd750
进行中（未招募）
不适用
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment ofGeographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) - Geographic Atrophy Treatment Evaluation (GATE)Geographic atrophy secondary to AMDMedDRA version: 14.0Level: LLTClassification code 10063947Term: Geographic atrophySystem Organ Class: 10015919 - Eye disordersEUCTR2008-007705-37-DEAlcon Research, Ltd750
进行中（未招募）
1 期
The Safety and Efficacy of AL-8309B Ophthalmic Solution for the Treatment ofGeographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) - Geographic Atrophy Treatment Evaluation (GATE)Geographic atrophy secondary to AMDMedDRA version: 14.0Level: LLTClassification code 10063947Term: Geographic atrophySystem Organ Class: 10015919 - Eye disordersEUCTR2008-007705-37-BEAlcon Research, Ltd750